Sponsored Content
dsm-firmenich, innovators in nutrition, health, and beauty, will award a total of €250,000 through its inaugural Nutrition Research Grant to five distinguished researchers from the Asia-Pacific region. Each recipient will receive an award of €50,000 to support up to 18 months of groundbreaking research aimed at advancing scientific understanding of gut health.
The Nutrition Research Grant was established to further nutrition research in the Asia-Pacific region by providing funding support for research conducted in Asia-Pacific to address research gaps on nutrition and health topics among the region’s populations.
The inaugural grant is centred on the theme “Health from the Gut across the Human Lifespan”, highlighting the growing recognition of gut health as a cornerstone of overall well-being across the Asia-Pacific region. dsm-firmenich, called for proposals to study the individual and synergistic roles of human milk oligosaccharides (HMOs), probiotics and postbiotics in segments such as early life nutrition, adult nutrition, and healthy aging. The aim is to deepen our understanding of the impact of various “biotics” on the gut microbiome and other health determinants in important areas such as metabolic health, immunity, and even mental health.
The Recipients and their Projects
dsm-firmenich’s Nutrition Research Grant recipients were selected through a rigorous evaluation process led by an international panel of experts in the gut microbiome field. Submissions came in from nine different countries in Asia pacific which were then assessed by the expert panel. The panel selected five proposals that demonstrated strong scientific merit, the potential to address critical health issues in the Asia-Pacific region, and a close alignment with this year's Grant’s theme of "Health from the Gut Across the Lifespan."
Selection criteria emphasized studies investigating HMOs and postbiotics, either independently or in combination with probiotics, to explore their effects on the gut microbiome and subsequent impacts on immunity, metabolism, aging, and mental health.
Anneleen Spooren, Senior Vice President, Innovation, R&D & Regulatory, Health, Nutrition and Care (HNC), dsm-firmenich remarked, “We were very impressed with the quality and depth of submissions we received. Applications came in from nine different countries across the Asia-Pacific region and we engaged two key-opinion leaders in microbiome and clinical nutrition to select the top five projects. We are excited to work closely with these researchers to uncover how different biotics can modulate the gut microbiome and to expand our knowledge of the microbiome-health relationship.”
The five dsm-firmenich Nutrition Research Grant recipients were:
Observational study: HMOs in Breastmilk and their relation to Gut Bifodobacterium, Vitamin D, and Immune Modulation in Infants
Randomised Controlled Trial: Assessing the Combination effect of Human Milk Oligosaccharides (HMOs) and probiotics on an Overweight Cohort
Pre-clinical study: Identification of Postbiotics and Human Milk Oligosaccharides (HMOs) that Improve Gut Microbiome and Host Health in Asian Adults
Animal model study: Postbiotics and Human Milk Oligosaccharides (HMOs) as a Modulator of Cellular Senescence by Enhancing Gut Barrier Function
Randomised Controlled Trial: Effects of Postbiotics on Mood Disorders in Korean Adults
“At dsm-firmenich, we are deeply committed to delivering science-backed solutions that elevate preventive health and address region-specific challenges,” said Tina Low, Senior Vice President, HNC, Asia-Pacific at dsm-firmenich. “The Nutrition Research Grant embodies our mission of 'together elevating health' by fostering collaboration with the scientific community to advance gut health research relevant to the unique lifestyles and diets of Asia-Pacific populations. Understanding the effects of our health-from-the-gut ingredients in this diverse region is critical to developing more tailored and efficacious solutions across life stages.”
23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more